Pre-exposure Prophylaxis Access in Federally Qualified Health Centers Across 11 United States Metropolitan Statistical Areas

Overview

Journal Int J STD AIDS

Specialty Infectious Diseases

Date 2019 Jul 10

PMID 31284842

Citations 8

Authors

Hansel Tookes

Kristiana Yao

Teresa Chueng

Stefani Butts

Ryan Karsner

Maria Duque

Gabriel Cardenas

Daniel J Feaster

Susanne Doblecki-Lewis

Affiliations

Soon will be listed here.

Citing Articles

Considerations for PrEP Implementation at Federally Qualified Health Centers in Mississippi: Perspectives From Staff and Patients.

Barnett A, Arnold T, Elwy A, Brock J, Giorlando K, Sims-Gomillia C AIDS Educ Prev. 2023; 35(4):309-319.

PMID: 37535326 PMC: 10483574. DOI: 10.1521/aeap.2023.35.4.309.

PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.

McNulty M, Kerman J, Devlin S, Pyra M, Rusie L, Curoe K AIDS Educ Prev. 2023; 35(3):235-246.

PMID: 37410372 PMC: 10328557. DOI: 10.1521/aeap.2023.35.3.235.

Protocol for WeExPAnd: a prospective, mixed-methods pilot demonstration study to increase access to pre-exposure prophylaxis among women vulnerable to HIV infection in the Southern USA.

Psaros C, Goodman G, McDonald V, Ott C, Blyler A, Rivas A BMJ Open. 2023; 13(6):e075250.

PMID: 37286316 PMC: 10255226. DOI: 10.1136/bmjopen-2023-075250.

Costs of Providing Preexposure Prophylaxis for HIV Prevention at Community Health Centers in the United States.

Shrestha R, Davis N, Coleman M, Rusie L, Smith D Public Health Rep. 2022; 138(5):763-770.

PMID: 36346165 PMC: 10467495. DOI: 10.1177/00333549221133071.

Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas.

Sharpe J, Sanchez T, Siegler A, Guest J, Sullivan P J Rural Health. 2022; 38(4):948-959.

PMID: 34997634 PMC: 9259757. DOI: 10.1111/jrh.12645.

References

Liu A, Kittredge P, Vittinghoff E, Raymond H, Ahrens K, Matheson T . Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008; 47(2):241-7. View

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

Mehta S, Silvera R, Bernstein K, Holzman R, Aberg J, Daskalakis D . Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City. Sex Transm Infect. 2011; 87(4):344-8. DOI: 10.1136/sti.2010.046284. View

Mansergh G, Koblin B, Sullivan P . Challenges for HIV pre-exposure prophylaxis among men who have sex with men in the United States. PLoS Med. 2012; 9(8):e1001286. PMC: 3424255. DOI: 10.1371/journal.pmed.1001286. View

Cahill S, Mayer K, Boswell S . The Ryan White HIV/AIDS Program in the Age of Health Care Reform. Am J Public Health. 2015; 105(6):1078-85. PMC: 4431102. DOI: 10.2105/AJPH.2014.302442. View

Zablotska I, Prestage G, Holt M, Poynten M, de Wit J, Guy R . Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods. J Acquir Immune Defic Syndr. 2011; 58(4):424-8. DOI: 10.1097/QAI.0b013e318230e885. View

Escudero D, Kerr T, Wood E, Nguyen P, Lurie M, Sued O . Acceptability of HIV Pre-exposure Prophylaxis (PREP) Among People Who Inject Drugs (PWID) in a Canadian Setting. AIDS Behav. 2014; 19(5):752-7. PMC: 4315758. DOI: 10.1007/s10461-014-0867-z. View

McCormack S, Dunn D, Desai M, Dolling D, Gafos M, Gilson R . Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015; 387(10013):53-60. PMC: 4700047. DOI: 10.1016/S0140-6736(15)00056-2. View

Adimora A, Ramirez C, Schoenbach V, Cohen M . Policies and politics that promote HIV infection in the Southern United States. AIDS. 2014; 28(10):1393-7. PMC: 4499462. DOI: 10.1097/QAD.0000000000000225. View

10.

Doblecki-Lewis S, Liu A, Feaster D, Cohen S, Cardenas G, Bacon O . Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project. J Acquir Immune Defic Syndr. 2016; 74(5):531-538. PMC: 5340616. DOI: 10.1097/QAI.0000000000001236. View

11.

Celum C, Baeten J . Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis. 2011; 25(1):51-7. PMC: 3266126. DOI: 10.1097/QCO.0b013e32834ef5ef. View

12.

Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock P, Leethochawalit M . Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013; 381(9883):2083-90. DOI: 10.1016/S0140-6736(13)61127-7. View

13.

Krakower D, Mayer K . Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012; 7(6):593-9. PMC: 3769645. DOI: 10.1097/COH.0b013e3283590446. View

14.

Golub S, Kowalczyk W, Weinberger C, Parsons J . Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr. 2010; 54(5):548-55. PMC: 2908204. DOI: 10.1097/QAI.0b013e3181e19a54. View

15.

Doblecki-Lewis S, Jones D . Community Federally Qualified Health Centers as Homes for HIV Preexposure Prophylaxis: Perspectives from South Florida. J Int Assoc Provid AIDS Care. 2016; 15(6):522-528. DOI: 10.1177/2325957416661422. View

16.

Lieb S, Prejean J, Thompson D, Fallon S, Cooper H, Gates G . HIV prevalence rates among men who have sex with men in the southern United States: population-based estimates by race/ethnicity. AIDS Behav. 2010; 15(3):596-606. DOI: 10.1007/s10461-010-9820-y. View